455 related articles for article (PubMed ID: 24446428)
1. Histological features of precancerous and early cancerous lesions of biliary tract carcinoma.
Aishima S; Kubo Y; Tanaka Y; Oda Y
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):448-52. PubMed ID: 24446428
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
Bickenbach K; Galka E; Roggin KK
Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
[TBL] [Abstract][Full Text] [Related]
3. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
Itatsu K; Zen Y; Ohira S; Ishikawa A; Sato Y; Harada K; Ikeda H; Sasaki M; Nimura Y; Nakanuma Y
Liver Int; 2007 Nov; 27(9):1174-84. PubMed ID: 17919228
[TBL] [Abstract][Full Text] [Related]
5. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
7. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
Wu TT; Levy M; Correa AM; Rosen CB; Abraham SC
Cancer; 2009 Oct; 115(19):4564-75. PubMed ID: 19670455
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
[TBL] [Abstract][Full Text] [Related]
9. Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma.
Kinoshita M; Kubo S; Nakanuma Y; Sato Y; Takemura S; Tanaka S; Hamano G; Ito T; Terajima H; Yamada T; Nakamori S; Arimoto A; Fujikawa M; Sugawara Y; Yamamoto T; Abue M; Nakagawa K; Unno M; Mizuguchi T; Takenaka K; Shirabe K; Shibata T
J Hepatobiliary Pancreat Sci; 2016 Feb; 23(2):92-101. PubMed ID: 26580863
[TBL] [Abstract][Full Text] [Related]
10. [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].
Schlitter AM; Klöppel G; Esposito I
Pathologe; 2013 Nov; 34 Suppl 2():235-40. PubMed ID: 24196621
[TBL] [Abstract][Full Text] [Related]
11. Premalignant lesions of cholangiocarcinoma: characteristics on ultrasonography and MRI.
Siripongsakun S; Sapthanakorn W; Mekraksakit P; Vichitpunt S; Chonyuen S; Seetasarn J; Bhumiwat S; Sricharunrat T; Srittanapong S
Abdom Radiol (NY); 2019 Jun; 44(6):2133-2146. PubMed ID: 30820627
[TBL] [Abstract][Full Text] [Related]
12. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
[TBL] [Abstract][Full Text] [Related]
13. Precancerous lesions of intrahepatic cholangiocarcinoma.
Shimonishi T; Sasaki M; Nakanuma Y
J Hepatobiliary Pancreat Surg; 2000; 7(6):542-50. PubMed ID: 11180885
[TBL] [Abstract][Full Text] [Related]
14. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
[TBL] [Abstract][Full Text] [Related]
15. Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia.
Sasaki M; Nitta T; Sato Y; Nakanuma Y
Hum Pathol; 2015 Feb; 46(2):202-9. PubMed ID: 25466963
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
17. Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis.
Rougemont AL; Genevay M; McKee TA; Gremaud M; Mentha G; Rubbia-Brandt L
Virchows Arch; 2010 Jun; 456(6):711-7. PubMed ID: 20428886
[TBL] [Abstract][Full Text] [Related]
18. Precancerous lesions of the biliary tree.
Klöppel G; Adsay V; Konukiewitz B; Kleeff J; Schlitter AM; Esposito I
Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):285-97. PubMed ID: 23809246
[TBL] [Abstract][Full Text] [Related]
19. Imaging Features of Premalignant Biliary Lesions and Predisposing Conditions with Pathologic Correlation.
Zulfiqar M; Chatterjee D; Yoneda N; Hoegger MJ; Ronot M; Hecht EM; Bastati N; Ba-Ssalamah A; Bashir MR; Fowler K
Radiographics; 2022; 42(5):1320-1337. PubMed ID: 35930475
[TBL] [Abstract][Full Text] [Related]
20. p53 protects against formation of extrahepatic biliary precancerous lesions in the context of oncogenic Kras.
Nagao M; Mizukoshi K; Nakayama S; Namikawa M; Hiramatsu Y; Maruno T; Nakanishi Y; Tsuruyama T; Fukuda A; Seno H
Oncotarget; 2023 Mar; 14():276-279. PubMed ID: 36999984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
